MAL and acute megakaryoblastic leukemia: JunB is a direct target of serum response factor (SRF), a ubiquitous transcription factor involved in smooth muscle proliferation, differentiation and contractility (reviewed in [33]), along with megakaryocytic acute leukemia (MAL), an SRF coactivator.